-
Robust detection of translocations in lymphoma FFPE samples using Targeted Locus Capture-based sequencing - NGS targeted capture control cohort
Study
EGAS00001005325
-
Clonal_dynamics_and_mutation_burden_in_male_germline___DupSeq
Study
EGAS00001005135
-
Mutational_landscape_in_haemochromatosis__exome_
Study
EGAS00001005158
-
Circulating tumor cells Exome sequencing from breast cancer
Study
EGAS00001005228
-
Combining a Universal Telomerase Based Cancer Vaccine with Ipilimumab in Patients with Metastatic Melanoma - Five-year Follow up of a Phase I/IIa Trial
Study
EGAS00001005253
-
PELICAN33 longitudinal clinical and autopsy phenomic assessment in lethal metastatic prostate cancer
Study
EGAS00001005399
-
Adult-type Granulosa Cell Tumour of the Ovary
Study
EGAS00001005414
-
Genomic and Transcriptomic Profile of Paired Primary-Metastasis Colorectal Tumors
Study
EGAS00001005276
-
Genomic Rearrangements in Pediatric Cancer
Study
EGAS00001005312
-
Targeted sequencing DDR genes in cancer stem cells
Study
EGAS00001004892
-
Res1_H23_exp1_MC_04_03_22
Study
EGAS00001006091
-
Detection and characterization of lung cancer using cell-free DNA fragmentomes
Study
EGAS00001005340
-
Unraveling the transcriptomic profile of utero-tubal lavage fluid of ovarian cancer patients
Study
EGAS00001005498
-
Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities
Study
EGAS00001004888
-
Expression-Based Subtypes Define Pathologic Response to Neoadjuvant Immune-Checkpoint Inhibitors in Muscle-Invasive Bladder Cancer
Study
EGAS00001005549
-
Sequence Data from the phase 2 PrE0505 trial of Durvalumab with First Line Platinum-Pemetrexed for Unresectable Pleural Mesothelioma
Study
EGAS00001005426
-
Whole exome sequencing on Pediatric MDS patients
Study
EGAS00001005432
-
Mutations in the RAS/MAPK pathway drive replication repair deficient hypermutated tumors and confer sensitivity to MEK inhibition
Study
EGAS00001005008
-
MutWP1__CRUK_Grand_Challenge_Mutographs_of_Cancer__head___neck
Study
EGAS00001005450
-
Human genomic and phenotypic synthetic data for the study of rare diseases
Study
EGAS00001005702
-
Combination_Immune_Checkpoint_Inhibition_in_Australian_Rare_Cancers_WES
Study
EGAS00001005709
-
MicroRNA profiling by next-generation sequencing for colorectal cancer screening
Study
EGAS00001005030
-
DERMATLAS__Porocarcinoma_RNAseq
Study
EGAS00001005721
-
The WID-BC-index identifies women with primary poor prognostic breast cancer based on DNA methylation in cervical samples
Study
EGAS00001005055
-
Clonal relationships of ductal carcinoma in situ and recurrent invasive breast cancers defined by genomic analysis
Study
EGAS00001005784
-
Molecular_risk_stratification_in_patients_with_T1_colorectal_cancer_WES
Study
EGAS00001005734
-
Panbody_nanoseq
Study
EGAS00001005521
-
The WID-CIN test identifies women with, and at risk of, cervical intraepithelial neoplasia grade 3 and invasive cervical cancer (CIN3+)
Study
EGAS00001005078
-
Detection of Cancer Mutations by Urine Liquid Biopsy in Bladder Cancer Patients
Study
EGAS00001005758
-
CRISPR transduction of iPS cells
Study
EGAS00001005102
-
Sequencing of cancer autopsies and ctDNA
Study
EGAS00001005109
-
Whole genome sequencing of a breast cancer cohort with known functional homologous recombination status
Study
EGAS00001005572
-
Genomics to select patients with metastatic breast cancer for targeted therapy (microarray_cytoscan)
Study
EGAS00001005584
-
Genetics and therapeutic responses to TIL therapy of pancreatic cancer PDX models
Study
EGAS00001005596
-
Gene expression-based prediction of pazopanib efficacy in sarcoma (HIPO, H021)
Study
EGAS00001005836
-
Chemotherapy accelerates genomic aging of normal blood in children treated for cancer
Study
EGAS00001005141
-
Targeted sequencing of paired tumour/blood of 34 T1 stage bladder cancer patients
Study
EGAS00001005767
-
Genetic and immune landscape evolution defines subtypes of MMR deficient colorectal cancer
Study
EGAS00001005769
-
arrayCGH for copy number profiling on tumor DNA from pediatric cancer tissue samples
Study
EGAS00001005197
-
Rare occurrence of Aristolochic Acid Mutational Signatures in Oro-Gastrointestinal Tract Cancers
Study
EGAS00001005909
-
Single-cell RNA sequencing of 6 follicular lymphoma tumors
Study
EGAS00001005257
-
Nanopore_and_Illumina_sequencing_of_human_glioblastomas
Study
EGAS00001005812
-
The evolutionary dynamics of human colorectal cancer using single-gland spatial multi-omic profiling of DNA, RNA and chromatin.
Study
EGAS00001005230
-
DNA sequencing for human normal endometrial glands
Study
EGAS00001005822
-
Genomic determination for Homologous Recombination Deficiency (HRD) by shallow Whole Genome Sequencing (sWGS)
Study
EGAS00001005926
-
Target gene sequencing for human normal endometrial glands
Study
EGAS00001005914
-
Exome-wide mutation analysis of cell-free DNA to simultaneously monitor the full spectrum of cancer treatment outcomes
Study
EGAS00001005906
-
The evolution of hematopoietic cells under cancer therapy
Study
EGAS00001005234
-
Non-coding mutations reveal cancer driver cistromes in luminal breast cancer
Study
EGAS00001005235
-
Ductal keratin 15+ luminal progenitors in normal breast exhibit a basal-like breast cancer transcriptomic signature
Study
EGAS00001005963
-
Longitudinal profiling of circulating tumour DNA for tracking tumour dynamics in pancreatic cancer
Study
EGAS00001005981
-
The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer
Study
EGAS00001005984
-
Tumor-intrinsic expression of the autophagy gene Atg16l1 suppresses anti-tumor immunity in colorectal cancer
Study
EGAS00001005952
-
Functional Mapping of AKT Signaling and Biomarkers of Response From the FAIRLANE Trial of Neoadjuvant Ipatasertib Plus Paclitaxel for Triple-Negative Breast Cancer
Study
EGAS00001005892
-
To determine the genomic profile of Triple Negative Breast Cancer patient-derived xenografts (PDX cohort)
Study
EGAS00001005995
-
Nucleosome footprinting in plasma cell-free DNA for diagnosis of ovarian cancer
Study
EGAS00001005361
-
Drug-induced epigenomic plasticity reprograms circadian rhythm regulation to drive prostate cancer towards androgen-independence (RNA-seq)
Study
EGAS00001006016
-
Pediatric Papillary Thyroid Carcinoma RNA-Seq
Study
EGAS00001005182
-
Methylome sequencing of cell-free DNA and RRBS of solid tissue
Study
EGAS00001006020
-
Genomic characterization of co-existing biliary tract intraepithelial neoplasia and carcinoma lesions reveals distinct evolutionary paths of gallbladder cancer
Study
EGAS00001005402
-
Identifying transcriptional programs underlying anti-EGFR small molecule response and resistance with TraCe-seq
Study
EGAS00001005405
-
The clinical utility of genomics in childhood cancer extends beyond targetable mutations
Study
EGAS00001006034
-
Genotyping by OncoArray and Global Screening Array for colorectal cancer risk prediction
Study
EGAS00001005411
-
Bulk RNA sequencing of Singapore colorectal cancer patients (SG-BULK)
Study
EGAS00001005978
-
NSCCG CRC GWAS data
Study
EGAS00001005412
-
Chromothripsis followed by circular recombination drives oncogene amplification in human cancer
Study
EGAS00001005424
-
Custom long non-coding RNA capture enhances detection sensitivity in different human sample types.
Study
EGAS00001005418
-
COIN CRC GWAS data
Study
EGAS00001005421
-
ANGIOPREDICT - an FP7-funded project enabling personalised medicine for patients with metastatic colorectal cancer.
Study
EGAS00001005423
-
Whole Genome sequencing of colorectal cancer patients (SG-BULK-3)
Study
EGAS00001006056
-
Genome analysis of early onset sporadic rectal cancer
Study
EGAS00001005970
-
Predictive value of chromosome 18q11.2-q12.1 loss for benefit from bevacizumab in metastatic colorectal cancer; a post-hoc analysis of the randomized controlled trial AGITG-MAX
Study
EGAS00001005453
-
Germline TP53 mutations undergo copy number gain years prior to tumor diagnosis
Study
EGAS00001005982
-
Res1_HT29_exp2_MC_03_03_22
Study
EGAS00001006093
-
Multimodal immunogenomic biomarker analysis of tumors from pediatric patients enrolled to a phase 1-2 study of single-agent atezolizumab
Study
EGAS00001006004
-
Spatio-temporal analysis of prostate tumors in situ suggests pre-existence of treatment-resistant clones
Study
EGAS00001006113
-
Cancer and germline exomes, and cancer RNA-seq consisiting of FASTQ paired-end reads from melanoma, lung and colon cancer samples
Study
EGAS00001005513
-
Whole genome sequencing of colorectal cancer patients (SG-BULK-1)
Study
EGAS00001006030
-
Genomewide copy number alteration screening of circulating plasma DNA
Study
EGAS00001006031
-
Spatial atlas of clonal copy number alterations in co-existing benign and malignant tissue
Study
EGAS00001006124
-
Understanding_the_multicellular_dynamics_of_clear_cell_renal_cell_carcinoma___visium
Study
EGAS00001006045
-
WGS of gastric cancer in the Japanese population (81 gastric cancers of NCC)
Study
EGAS00001006051
-
Germline variants in patients with rare cancers and their implications for precision cancer medicine: experiences from the Multicenter MASTER Trial by the German Cancer Consortium (HIPO_021)
Study
EGAS00001005537
-
To determine the genomic profiles of Triple Negative Breast Cancers (COH cohort)
Study
EGAS00001006085
-
Genomic profiling of Follicular thyroid adenomas and carcinomas using exome-sequencing analyses
Study
EGAS00001005561
-
Genomics to select patients with metastatic breast cancer for targeted therapy (microarray_agilent)
Study
EGAS00001005587
-
Genomics to select patients with metastatic breast cancer for targeted therapy (microarray_oncoscan)
Study
EGAS00001005586
-
Whole Genome sequencing of colorectal cancer patients (SG-BULK-5)
Study
EGAS00001006114
-
Salivary Gland Cancer TSO500 dataset
Study
EGAS00001006232
-
The genomic landscape of serrated lesion of the colorectum
Study
EGAS00001005648
-
Res1_PC9_exp1_MC_29_03_22
Study
EGAS00001006169
-
Characterization of Cell Free Plasma Methyl-DNA From Xenografted Tumors to Guide the Selection of Diagnostic Markers for Early-Stage Cancers
Study
EGAS00001006175
-
Proteogenomics of chronic lymphocytic leukemia
Study
EGAS00001005746
-
Accurate detection of tumor-specific fusion genes reveals strongly immunogenic personal neo-antigens
Study
EGAS00001004877
-
Single_cell_characterization_of_T_cell_lymphoma_
Study
EGAS00001005750
-
Whole-exome sequencing of paired tumour/blood of 58 T1 stage bladder cancer patients
Study
EGAS00001005765
-
Heat selection enables highly scalable methylome profiling in cell-free DNA for noninvasive monitoring of cancer patients
Study
EGAS00001006198
-
The immunopeptidome landscape associated with T cell infiltration, inflammation and immune-editing in lung cancer
Study
EGAS00001006298
-
Defining structural variation associated with breast cancer susceptibility by long-read genome sequencing
Study
EGAS00001005872
-
Comprehensive characterization of pre- and post-treatment samples of breast cancer reveal potential mechanisms of chemotherapy resistance
Study
EGAS00001005876